Balansräkning Pfizer Inc.

Aktier

PFE

US7170811035

Farmaceutiska produkter

Marknaden stängd - NYSE Andra börsplatser 22.01.30 2026-07-17			Efter stängning 22.26.10
25,05 ^USD	−0,36 %		25,09	+0,16 %

06.56	USA viktiga bolag - Abbott Laboratories ökade 10,7 procent	FW
07-16	Pfizer stoppar försäljningen av Premarin i Indien – hänvisar till leveransproblem	RE

2490c70fb21c9655c0aa9aa98f.OeP7hciu0QBBpGl293-hLolTcRLo9yyc0YP0gzWnXOs.dqaDz7vtgFZxkQdAuk7ua-wfFX_Rj0v-q9WrzQ3FFp4U0cjTnfupZw_SUQ

Publicerade finansiella data: PFIZER INC.

Årlig

Kvartalsvis

Halvårsvis

YTD

LTM

Skatteperiod: December	2021	2022	2023	2024	2025
Revenues	81,29 md	100 md	58,5 md	63,63 md	62,58 md
Total Revenues	81,29 md	100 md	58,5 md	63,63 md	62,58 md
Cost of Goods Sold, Total	30,66 md	34,1 md	23,99 md	17,19 md	15,14 md
Gross Profit	50,63 md	66,23 md	34,51 md	46,44 md	47,44 md
Selling General & Admin Expenses, Total	9,56 md	12,2 md	13,84 md	14,77 md	12,96 md
R&D Expenses	10,52 md	11,43 md	10,68 md	10,74 md	10,44 md
Amortization of Goodwill and Intangible Assets - (IS)	3,7 md	3,61 md	4,73 md	5,29 md	4,87 md
Other Operating Expenses, Total	23,78 md	27,24 md	29,25 md	30,8 md	28,28 md
Operating Income	26,84 md	39 md	5,26 md	15,64 md	19,16 md
Interest Expense, Total	−1,29 md	−1,24 md	−2,21 md	−3,09 md	−2,67 md
Interest And Investment Income	202 mn	565 mn	2,1 md	817 mn	868 mn
Net Interest Expenses	−1,09 md	−673 mn	−109 mn	−2,27 md	−1,8 md
Income (Loss) On Equity Invest.	471 mn	436 mn	505 mn	102 mn	-
Currency Exchange Gains (Loss)	−192 mn	−1,15 md	164 mn	50 mn	-
Other Non Operating Income (Expenses)	1,88 md	2,62 md	1,28 md	652 mn	1,55 md
EBT, Excl. Unusual Items	27,92 md	40,22 md	7,09 md	14,17 md	18,91 md
Restructuring Charges	−1,36 md	−2,02 md	−3,33 md	−2,73 md	−1,85 md
Merger & Related Restructuring Charges	-	−200 mn	−668 mn	−1,4 md	−773 mn
Gain (Loss) On Sale Of Investments	1,34 md	−1,27 md	1,59 md	1,83 md	−134 mn
Gain (Loss) On Sale Of Assets	99 mn	-	222 mn	−420 mn	-
Asset Writedown	−86 mn	−421 mn	−3,02 md	−3,3 md	−4,94 md
In Process R&D Expenses	-	−953 mn	−194 mn	−108 mn	−1,61 md
Insurance Settlements	-	-	-	-	-
Legal Settlements	−182 mn	−230 mn	−474 mn	−567 mn	−1,06 md
Other Unusual Items	−3,42 md	−394 mn	−157 mn	532 mn	−1,02 md
EBT, Incl. Unusual Items	24,31 md	34,73 md	1,06 md	8,02 md	7,52 md
Income Tax Expense	1,85 md	3,33 md	−1,12 md	−28 mn	−266 mn
Earnings From Continuing Operations	22,46 md	31,4 md	2,17 md	8,05 md	7,79 md
Earnings Of Discontinued Operations	−434 mn	6 mn	−15 mn	11 mn	25 mn
Net Income to Company	22,02 md	31,41 md	2,16 md	8,06 md	7,81 md
Minority Interest	−45 mn	−35 mn	−39 mn	−31 mn	−41 mn
Net Income - (IS)	21,98 md	31,37 md	2,12 md	8,03 md	7,77 md
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	21,98 md	31,37 md	2,12 md	8,03 md	7,77 md
Net Income to Common Excl. Extra Items	22,41 md	31,37 md	2,13 md	8,02 md	7,75 md
Per aktie poster
Net EPS - Basic	3,92	5,59	0,38	1,42	1,37
Basic EPS - Continuing Operations	4	5,59	0,38	1,42	1,36
Basic Weighted Average Shares Outstanding	5,6 md	5,61 md	5,64 md	5,66 md	5,68 md
Net EPS - Diluted	3,85	5,47	0,37	1,41	1,36
Diluted EPS - Continuing Operations	3,93	5,47	0,37	1,41	1,36
Diluted Weighted Average Shares Outstanding	5,71 md	5,73 md	5,71 md	5,7 md	5,71 md
Normalized Basic EPS	3,11	4,48	0,78	1,56	2,07
Normalized Diluted EPS	3,05	4,38	0,77	1,55	2,06
Dividend Per Share	1,56	1,6	1,64	1,68	1,72
Payout Ratio	39,72	28,63	436,38	118,44	125,74
American Depositary Receipts Ratio (ADR)	0,25	0,25	0,25	0,25	0,25
Kompletterande punkter
EBITDA	31,95 md	44,02 md	11,52 md	22,64 md	25,72 md
EBITA	30,54 md	42,6 md	9,99 md	20,93 md	24,04 md
EBIT	26,84 md	39 md	5,26 md	15,64 md	19,16 md
EBITDAR	32,84 md	45,24 md	12,8 md	23,81 md	26,64 md
Total Revenues (As Reported)	-	-	58,5 md	63,63 md	62,58 md
Effective Tax Rate - (Ratio)	7,62	9,58	−105,39	−0,35	−3,54
Current Domestic Taxes	3,38 md	2,72 md	1,19 md	485 mn	556 mn
Current Foreign Taxes	2,77 md	4,37 md	1,14 md	1,59 md	1,31 md
Total Current Taxes	6,14 md	7,09 md	2,33 md	2,07 md	1,87 md
Deferred Domestic Taxes	−4,34 md	−3,58 md	−2,79 md	−2,2 md	−1,89 md
Deferred Foreign Taxes	48 mn	−183 mn	−652 mn	100 mn	−246 mn
Total Deferred Taxes	−4,29 md	−3,76 md	−3,44 md	−2,1 md	−2,13 md
Normalized Net Income	17,4 md	25,11 md	4,39 md	8,83 md	11,78 md
Interest Capitalized	108 mn	124 mn	160 mn	182 mn	166 mn
Non-Cash Pension Expense	−2,14 md	−247 mn	−508 mn	150 mn	−506 mn
Kompletterande driftskostnadsposter
Advertising Expense	2 md	2,8 md	3,7 md	3,3 md	2,7 md
Selling and Marketing Expenses	2 md	2,8 md	3,7 md	3,3 md	2,7 md
Research And Development Expense From Footnotes	13,83 md	11,43 md	10,87 md	10,93 md	12,05 md
Net Rental Expense, Total	888 mn	1,22 md	1,28 md	1,18 md	924 mn
Imputed Operating Lease Interest Expense	240 mn	329 mn	424 mn	432 mn	311 mn
Imputed Operating Lease Depreciation	648 mn	889 mn	859 mn	745 mn	613 mn
Stock-Based Comp., Other (Total)	1,2 md	891 mn	545 mn	893 mn	799 mn
Total Stock-Based Compensation	1,2 md	891 mn	545 mn	893 mn	799 mn

Skatteperiod: December	2021	2022	2023	2024	2025
TILLGÅNGAR
Cash And Equivalents	1,94 md	416 mn	2,85 md	1,04 md	1,14 md
Short Term Investments	29,12 md	22,32 md	9,84 md	19,43 md	12,45 md
Trading Asset Securities, Total	4 mn	-	-	-	-
Total Cash And Short Term Investments	31,07 md	22,73 md	12,69 md	20,48 md	13,6 md
Accounts Receivable, Total	11,48 md	10,95 md	11,18 md	11,46 md	11,87 md
Other Receivables	4,27 md	3,58 md	3,98 md	3,31 md	3,97 md
Total Receivables	15,74 md	14,53 md	15,16 md	14,78 md	15,84 md
Inventory	9,06 md	8,98 md	10,19 md	10,85 md	10,65 md
Other Current Assets, Total	3,82 md	5,02 md	5,3 md	4,25 md	2,81 md
Total Current Assets	59,69 md	51,26 md	43,33 md	50,36 md	42,9 md
Gross Property Plant And Equipment	32,8 md	34,45 md	37,91 md	37,16 md	38,92 md
Accumulated Depreciation	−15,07 md	−15,17 md	−16,04 md	−16,48 md	−17,39 md
Net Property Plant And Equipment	17,72 md	19,28 md	21,86 md	20,68 md	21,53 md
Long-term Investments	21,54 md	14,93 md	15,38 md	2,11 md	1,53 md
Goodwill	49,21 md	51,38 md	67,78 md	68,53 md	71,26 md
Other Intangibles, Total	25,15 md	43,37 md	64,9 md	55,41 md	53,73 md
Deferred Tax Assets Long-Term	1,6 md	4,8 md	1,8 md	6,6 md	7,4 md
Other Long-Term Assets, Total	6,57 md	12,2 md	11,44 md	9,71 md	9,81 md
Total Assets	181 md	197 md	227 md	213 md	208 md
Skulder
Accounts Payable, Total	5,58 md	6,81 md	6,71 md	5,63 md	5,24 md
Accrued Expenses, Total	7,67 md	8,32 md	9,22 md	12 md	12,27 md
Short-term Borrowings	605 mn	385 mn	8,1 md	3,2 md	157 mn
Current Portion of Long-Term Debt	1,64 md	2,57 md	2,27 md	3,78 md	3,01 md
Current Portion of Leases	449 mn	620 mn	527 mn	356 mn	330 mn
Current Income Taxes Payable	1,27 md	1,59 md	2,35 md	2,91 md	3,1 md
Unearned Revenue Current, Total	4,02 md	2,52 md	2,7 md	1,51 md	784 mn
Other Current Liabilities	21,44 md	19,33 md	15,92 md	13,61 md	12,09 md
Total Current Liabilities	42,67 md	42,14 md	47,79 md	43 md	36,98 md
Long-Term Debt	36,2 md	33,2 md	61,81 md	57,8 md	61,86 md
Long-Term Leases	2,51 md	2,6 md	2,63 md	2,29 md	2,29 md
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	3,72 md	2,25 md	2,17 md	2,12 md	2,04 md
Deferred Tax Liability Non Current	349 mn	1,02 md	640 mn	2,12 md	2,4 md
Other Non Current Liabilities	18,56 md	20,08 md	22,17 md	17,58 md	15,81 md
Total Liabilities	104 md	101 md	137 md	125 md	121 md
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	473 mn	476 mn	478 mn	480 mn	481 mn
Additional Paid In Capital	90,59 md	91,8 md	92,63 md	93,6 md	94,47 md
Retained Earnings	103 md	126 md	118 md	117 md	115 md
Treasury Stock	−111 md	−114 md	−114 md	−115 md	−115 md
Comprehensive Income and Other	−5,9 md	−8,3 md	−7,96 md	−7,84 md	−8,07 md
Total Common Equity	77,2 md	95,66 md	89,01 md	88,2 md	86,48 md
Minority Interest	262 mn	256 mn	274 mn	294 mn	299 mn
Total Equity	77,46 md	95,92 md	89,29 md	88,5 md	86,78 md
Total Liabilities And Equity	181 md	197 md	227 md	213 md	208 md
Kompletterande objekt
ECS Total Shares Outstanding on Filing Date	5,62 md	5,62 md	5,65 md	5,67 md	5,69 md
ECS Total Common Shares Outstanding	5,62 md	5,62 md	5,65 md	5,67 md	5,69 md
Book Value / Share	13,74	17,03	15,77	15,56	15,21
Tangible Book Value	2,85 md	916 mn	−43,67 md	−35,74 md	−38,52 md
Tangible Book Value Per Share	0,51	0,16	−7,73	−6,31	−6,77
Total Debt	41,4 md	39,38 md	75,33 md	67,42 md	67,65 md
Net Debt	10,32 md	16,64 md	62,64 md	46,94 md	54,05 md
Debt Equivalent of Unfunded Proj. Benefit Obligation	1,73 md	1,18 md	561 mn	500 mn	−23 mn
Debt Equivalent Oper. Leases	7,1 md	9,74 md	10,26 md	9,42 md	7,39 md
Minority Interest, Total (Incl. Fin. Div)	262 mn	256 mn	274 mn	294 mn	299 mn
Equity Method Investments, Total	16,47 md	11,03 md	11,64 md	217 mn	235 mn
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	994 mn	859 mn	1,01 md	976 mn	907 mn
Inventories - Work In Process, Total	4,42 md	5,52 md	5,69 md	6,1 md	5,63 md
Inventories - Finished Goods, Total	3,64 md	2,6 md	3,5 md	3,78 md	4,11 md
Land - (BS)	423 mn	368 mn	353 mn	291 mn	299 mn
Buildings, Total	9 md	8,83 md	9,05 md	9,04 md	9,74 md
Machinery, Total	16,71 md	17,37 md	19,66 md	20,61 md	21,86 md
Full Time Employees	79 tn	83 tn	88 tn	81 tn	75 tn
Accumulated Allowance for Doubtful Accounts (Supple)	492 mn	449 mn	470 mn	438 mn	427 mn

Skatteperiod: December	2021	2022	2023	2024	2025
Net Income	21,98 md	31,37 md	2,12 md	8,03 md	7,77 md
Depreciation & Amortization - CF	1,4 md	1,42 md	1,52 md	1,71 md	1,68 md
Amortization of Goodwill and Intangible Assets - (CF)	3,7 md	3,61 md	4,73 md	5,29 md	4,87 md
Depreciation & Amortization, Total	5,1 md	5,03 md	6,26 md	6,99 md	6,55 md
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	363 mn	586 mn	3,44 md	4,26 md	5,31 md
Stock-Based Compensation (CF)	1,18 md	872 mn	525 mn	877 mn	799 mn
Net Cash From Discontinued Operations	−343 mn	-	15 mn	−11 mn	−25 mn
Other Operating Activities, Total	−8,51 md	−4,14 md	−1,48 md	−4,34 md	−3,35 md
Change In Accounts Receivable	−3,81 md	261 mn	347 mn	−109 mn	−263 mn
Change In Inventories	−1,12 md	592 mn	−1,17 md	−854 mn	561 mn
Change In Accounts Payable	1,24 md	1,19 md	−300 mn	−1,02 md	−469 mn
Change in Other Net Operating Assets	16,5 md	−6,5 md	−1,05 md	−1,08 md	−5,18 md
Cash from Operations	32,58 md	29,27 md	8,7 md	12,74 md	11,7 md
Capital Expenditure	−2,71 md	−3,24 md	−3,91 md	−2,91 md	−2,63 md
Cash Acquisitions	-	−23 md	−43,43 md	-	−6,93 md
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	−19,52 md	6,68 md	15,24 md	5,56 md	8,04 md
Other Investing Activities, Total	−318 mn	3,77 md	−180 mn	0	165 mn
Cash from Investing	−22,55 md	−15,78 md	−32,28 md	2,65 md	−1,35 md
Short Term Debt Issued, Total	-	3,89 md	7,69 md	8,91 md	-
Long-Term Debt Issued, Total	997 mn	-	30,83 md	-	9,68 md
Total Debt Issued	997 mn	3,89 md	38,52 md	8,91 md	9,68 md
Short Term Debt Repaid, Total	−96 mn	−4,11 md	−3 mn	−13,82 md	−3 md
Long-Term Debt Repaid, Total	−2 md	−3,3 md	−2,57 md	−2,25 md	−6,76 md
Total Debt Repaid	−2,1 md	−7,41 md	−2,57 md	−16,07 md	−9,75 md
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	−2 md	-	-	-
Common Dividends Paid	−8,73 md	−8,98 md	−9,25 md	−9,51 md	−9,77 md
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	−8,73 md	−8,98 md	−9,25 md	−9,51 md	−9,77 md
Other Financing Activities, Total	16 mn	−335 mn	−632 mn	−469 mn	−459 mn
Cash from Financing	−9,82 md	−14,83 md	26,07 md	−17,14 md	−10,3 md
Foreign Exchange Rate Adjustments	−59 mn	−165 mn	−40 mn	−66 mn	41 mn
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	159 mn	−1,52 md	2,45 md	−1,81 md	90 mn
Kompletterande punkter
Cash Interest Paid	1,47 md	1,44 md	2,22 md	3,23 md	2,74 md
Cash Income Tax Paid (Refund)	7,43 md	7,87 md	3,15 md	3,6 md	4,69 md
Levered Free Cash Flow	30,86 md	24,96 md	1,02 md	12,35 md	13,43 md
Unlevered Free Cash Flow	31,66 md	25,73 md	2,4 md	14,28 md	15,1 md
Change In Net Working Capital	−11,29 md	1,32 md	3,78 md	474 mn	1,6 md
Net Debt Issued / Repaid	−1,1 md	−3,52 md	35,94 md	−7,16 md	−74 mn

Skatteperiod: December	2021	2022	2023	2024	2025
Lönsamhet
Return on Assets	10	12,87	1,55	4,44	5,68
Return on Total Capital	15,01	19,18	2,19	6,1	7,72
Return On Equity %	31,87	36,22	2,35	9,06	8,89
Return on Common Equity	31,92	36,29	2,31	9,05	8,87
Marginalanalys
Gross Profit Margin %	62,28	66,02	58,99	72,98	75,81
SG&A Margin	11,77	12,16	23,65	23,21	20,72
EBITDA Margin %	39,3	43,88	19,69	35,57	41,1
EBITA Margin %	37,58	42,46	17,08	32,89	38,41
EBIT Margin %	33,02	38,87	8,99	24,58	30,62
Income From Continuing Operations Margin %	27,63	31,3	3,71	12,65	12,44
Net Income Margin %	27,04	31,27	3,62	12,62	12,42
Net Avail. For Common Margin %	27,57	31,26	3,65	12,6	12,38
Normalized Net Income Margin	21,41	25,02	7,51	13,87	18,82
Levered Free Cash Flow Margin	37,96	24,87	1,75	19,41	21,46
Unlevered Free Cash Flow Margin	38,95	25,65	4,11	22,44	24,13
Tillgångsomslutning
Asset Turnover	0,48	0,53	0,28	0,29	0,3
Fixed Assets Turnover	4,95	5,42	2,84	2,99	2,96
Receivables Turnover (Average Receivables)	8,38	8,95	5,29	5,53	5,36
Inventory Turnover (Average Inventory)	3,59	3,78	2,5	1,63	1,41
Kortfristig likviditet
Current Ratio	1,4	1,22	0,91	1,17	1,16
Quick Ratio	1,1	0,88	0,58	0,82	0,8
Operating Cash Flow to Current Liabilities	0,76	0,69	0,18	0,3	0,32
Days Sales Outstanding (Average Receivables)	43,54	40,8	69,04	66,23	68,06
Days Outstanding Inventory (Average Inventory)	101,66	96,56	145,84	223,97	259,22
Average Days Payable Outstanding	56,77	66,45	97,92	126,52	132,79
Cash Conversion Cycle (Average Days)	88,42	70,91	116,96	163,69	194,49
Långsiktig solvens
Total Debt/Equity	53,44	41,05	84,37	76,18	77,96
Total Debt / Total Capital	34,83	29,1	45,76	43,24	43,81
LT Debt/Equity	49,97	37,33	72,17	67,9	73,92
Long-Term Debt / Total Capital	32,56	26,46	39,14	38,54	41,54
Total Liabilities / Total Assets	57,32	51,36	60,58	58,53	58,31
EBIT / Interest Expense	20,79	31,5	2,38	5,06	7,17
EBITDA / Interest Expense	25,44	36,54	5,79	7,7	9,97
(EBITDA - Capex) / Interest Expense	23,34	33,93	4,03	6,76	8,99
Total Debt / EBITDA	1,26	0,87	5,89	2,83	2,54
Net Debt / EBITDA	0,31	0,37	4,89	1,97	2,03
Total Debt / (EBITDA - Capex)	1,37	0,94	8,47	3,23	2,82
Net Debt / (EBITDA - Capex)	0,34	0,4	7,04	2,25	2,25
Tillväxt jämfört med föregående år
Total Revenues, 1 Yr. Growth %	95,16	23,43	−41,7	6,84	−1,65
Gross Profit, 1 Yr. Growth %	52,11	30,89	−47,9	11,19	2,16
EBITDA, 1 Yr. Growth %	123,2	37,21	−73,84	19,92	14,04
EBITA, 1 Yr. Growth %	135	38,87	−76,55	20,62	15,33
EBIT, 1 Yr. Growth %	178,19	44,54	−86,51	23,97	23,19
Earnings From Cont. Operations, 1 Yr. Growth %	236,9	39,82	−93,08	270,5	−3,28
Net Income, 1 Yr. Growth %	139,97	42,74	−93,25	279	−3,24
Normalized Net Income, 1 Yr. Growth %	168,88	42,98	−82,5	5,92	43,19
Diluted EPS Before Extra, 1 Yr. Growth %	233,05	39,19	−93,24	281,08	−3,55
Accounts Receivable, 1 Yr. Growth %	45,06	−4,59	2,05	−0,89	3,59
Inventory, 1 Yr. Growth %	12,96	−0,86	13,45	6,5	−1,82
Net Property, Plant and Equip., 1 Yr. Growth %	17,12	8,77	13,43	−5,41	4,1
Total Assets, 1 Yr. Growth %	17,67	8,67	14,86	−5,79	−2,45
Tangible Book Value, 1 Yr. Growth %	−119,43	−67,83	−4,87 tn	−18,17	7,79
Common Equity, 1 Yr. Growth %	22,08	23,91	−6,95	−0,91	−1,96
Cash From Operations, 1 Yr. Growth %	126,2	−10,17	−70,27	46,48	−8,16
Capital Expenditures, 1 Yr. Growth %	21,79	19,37	20,74	−25,54	−9,63
Levered Free Cash Flow, 1 Yr. Growth %	189,11	−19,34	−95,9	119,59	9,37
Unlevered Free Cash Flow, 1 Yr. Growth %	173,46	−18,95	−90,65	103,89	6,25
Dividend Per Share, 1 Yr. Growth %	2,63	2,56	2,5	2,44	2,38
Sammansatt Årlig Tillväxthastighet Över Två År
Total Revenues, 2 Yr. CAGR %	40,97	55,2	−15,17	−20,7	2,51
Gross Profit, 2 Yr. CAGR %	23,75	41,1	−17,42	−16,8	15,49
EBITDA, 2 Yr. CAGR %	51,84	74,52	−40,09	−28,98	43,01
EBITA, 2 Yr. CAGR %	55,88	80,07	−42,93	−30,6	47,49
EBIT, 2 Yr. CAGR %	81,58	99,57	−55,85	−37,34	74,18
Earnings From Cont. Operations, 2 Yr. CAGR %	44,63	117,04	−68,89	−49,36	89,3
Net Income, 2 Yr. CAGR %	17,11	85,07	−68,95	−49,4	91,5
Normalized Net Income, 2 Yr. CAGR %	82,62	94,92	−50,06	−40,71	79,3
Diluted EPS Before Extra, 2 Yr. CAGR %	44,32	115,3	−69,32	−49,23	91,72
Accounts Receivable, 2 Yr. CAGR %	30,19	17,65	−1,32	2,31	1,32
Inventory, 2 Yr. CAGR %	13,21	5,82	6,05	9,92	2,26
Net Property, Plant and Equip., 2 Yr. CAGR %	11,48	12,87	11,08	3,58	−0,77
Total Assets, 2 Yr. CAGR %	4,06	13,08	11,72	4,02	−4,13
Tangible Book Value, 2 Yr. CAGR %	−61,3	−75	291,65	524,6	−6,08
Common Equity, 2 Yr. CAGR %	10,59	22,99	7,38	−3,98	−1,44
Cash From Operations, 2 Yr. CAGR %	60,88	42,55	−48,32	−34,01	15,99
Capital Expenditures, 2 Yr. CAGR %	15,11	20,57	20,05	−5,19	−17,97
Levered Free Cash Flow, 2 Yr. CAGR %	47,45	52,29	−81,81	−30,39	183,97
Unlevered Free Cash Flow, 2 Yr. CAGR %	44,45	48,51	−72,48	−26,26	122,64
Dividend Per Share, 2 Yr. CAGR %	4,08	2,6	2,53	2,47	2,41
Treårig Sammansatt Årlig Tillväxthastighet
Total Revenues, 3 Yr. CAGR %	25,81	34,86	11,99	−7,84	−14,8
Gross Profit, 3 Yr. CAGR %	16,58	26,07	1,23	−2,82	−10,91
EBITDA, 3 Yr. CAGR %	33,37	47,01	−7,29	−10,98	−16,93
EBITA, 3 Yr. CAGR %	36,19	50,21	−8,72	−11,97	−17,91
EBIT, 3 Yr. CAGR %	53,97	68,56	−18,71	−16,62	−21,65
Earnings From Cont. Operations, 3 Yr. CAGR %	79,84	43,01	−31,18	−28,96	−37,17
Net Income, 3 Yr. CAGR %	25,37	25,09	−38,61	−28,51	−37,2
Normalized Net Income, 3 Yr. CAGR %	54,32	68,81	−12,71	−20,58	−22,3
Diluted EPS Before Extra, 3 Yr. CAGR %	83,13	42,59	−32,06	−28,94	−37,12
Accounts Receivable, 3 Yr. CAGR %	12,67	17,38	12,2	−0,05	2,73
Inventory, 3 Yr. CAGR %	6,46	8,31	8,31	6,2	5,86
Net Property, Plant and Equip., 3 Yr. CAGR %	9,81	10,57	13,05	5,29	3,76
Total Assets, 3 Yr. CAGR %	4,41	5,57	13,67	5,55	1,82
Tangible Book Value, 3 Yr. CAGR %	−51,68	−63,61	43,9	132,4	247,74
Common Equity, 3 Yr. CAGR %	6,79	14,86	12,07	4,54	−3,31
Cash From Operations, 3 Yr. CAGR %	27,21	32,48	−15,47	−26,87	−26,33
Capital Expenditures, 3 Yr. CAGR %	10,97	16,51	20,63	2,38	−6,69
Levered Free Cash Flow, 3 Yr. CAGR %	188,1	20,7	−54,34	−26,38	−19,23
Unlevered Free Cash Flow, 3 Yr. CAGR %	146,54	19,25	−40,93	−23,38	−16,84
Dividend Per Share, 3 Yr. CAGR %	4,68	3,57	2,57	2,5	2,44
Sammansatt Årlig Tillväxthastighet Över Fem År
Total Revenues, 5 Yr. CAGR %	9	13,81	7,46	9,24	8,48
Gross Profit, 5 Yr. CAGR %	4,36	9,68	1,55	7,03	7,36
EBITDA, 5 Yr. CAGR %	10,21	16,08	−3,08	10,31	12,21
EBITA, 5 Yr. CAGR %	10,97	16,96	−3,74	10,73	12,84
EBIT, 5 Yr. CAGR %	13,75	21,53	−6,49	13,95	14,38
Earnings From Cont. Operations, 5 Yr. CAGR %	25,44	8,02	−10,86	−5,6	3,16
Net Income, 5 Yr. CAGR %	24,96	8,04	−28,26	−12,91	−3,23
Normalized Net Income, 5 Yr. CAGR %	13,75	22,41	−1,48	11,08	12,26
Diluted EPS Before Extra, 5 Yr. CAGR %	27,42	9,24	−10,38	−5,66	2,88
Accounts Receivable, 5 Yr. CAGR %	6,89	5,9	6,85	11,1	8,46
Inventory, 5 Yr. CAGR %	5,96	3,46	6,3	8,95	5,84
Net Property, Plant and Equip., 5 Yr. CAGR %	5,88	6,81	10,31	7,72	7,31
Total Assets, 5 Yr. CAGR %	1,12	2,8	7,28	4,95	6,18
Tangible Book Value, 5 Yr. CAGR %	−43,06	−51,29	11,59	13,45	21,32
Common Equity, 5 Yr. CAGR %	5,34	6,06	7,03	6,92	6,46
Cash From Operations, 5 Yr. CAGR %	15,01	11,74	−11,28	0,25	−4,07
Capital Expenditures, 5 Yr. CAGR %	8,26	10,59	14,51	7,29	3,38
Levered Free Cash Flow, 5 Yr. CAGR %	18,96	13,44	−4,51	−2,75	4,53
Unlevered Free Cash Flow, 5 Yr. CAGR %	18,25	12,82	2,62	−1,21	5,29
Dividend Per Share, 5 Yr. CAGR %	5,39	4,56	3,82	3,13	2,5